货号:GS40649
Serplulimab is a humanized monoclonal antibody targeting programmed cell death protein 1 (PD-1). It binds to PD-1 on T cells, blocking its interaction with PD-L1/PD-L2 ligands to reverse T cell exhaustion and enhance anti-tumor immunity. It is approved in China for the treatment of microsatellite instability-high (MSI-H) solid tumors, non-small cell lung cancer, and esophageal squamous cell carcinoma.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
迈思生物